| ²é¿´: 1002 | »Ø¸´: 4 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
yyt_99ľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖúÀ×±´ÀßòÔÚThomson pharmaÊý¾Ý¿â»¹ÓÐĬ¿ËË÷ÒýÖеļìË÷½á¹û
|
||
| ÇóÖúÀ×±´ÀßòÔÚThomson pharmaÊý¾Ý¿â»¹ÓÐĬ¿ËË÷ÒýÖеļìË÷½á¹û£¬×îºÃÊÇÊä³öWORDµÄÐÎʽ£¬¸ø¸öÇåÎúµÄ½ØÍ¼Ò²ÐУ¬ÉÏ´«ÏÂÎļþ£¬Âé·³ÁË£¬×ż±¡£ |
» ²ÂÄãϲ»¶
ҩѧѧ˶326Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
105500ҩѧµ÷¼Á£¬Ò»Ö¾Ô¸¶¥9£¬Ö÷³ÖÊ¡¼¶´ó´´£¬ÊµÑéÐÍSCI¶þ×÷£¬ËÄÁù¼¶Òѹý£¬Ë«¹ú½±
ÒѾÓÐ6È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ123È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
ҩѧר˶µ÷¼Á
ÒѾÓÐ0È˻ظ´
publcifµÄʹÓÃ
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
»á¼Æ×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
ÒѾÓÐ14È˻ظ´
Çë½Ìõ£°·ËõºÏ·´Ó¦
ÒѾÓÐ2È˻ظ´

zhanyf
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 35 (СѧÉú)
- ½ð±Ò: 4206.4
- ºì»¨: 31
- Ìû×Ó: 169
- ÔÚÏß: 142.4Сʱ
- ³æºÅ: 1387650
- ×¢²á: 2011-09-02
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
marktiger: ½ð±Ò+1, лл²ÎÓ룬»¶Ó³£À´¡£ 2012-11-12 08:32:23
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
marktiger: ½ð±Ò+1, лл²ÎÓ룬»¶Ó³£À´¡£ 2012-11-12 08:32:23
|
Ĭ¿ËË÷ÒýÈçÏ£º Title: Rabeprazole CAS Registry Number: 117976-89-3 CAS Name: 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole Additional Names: pariprazole Molecular Formula: C18H21N3O3S Molecular Weight: 359.44 Percent Composition: C 60.15%, H 5.89%, N 11.69%, O 13.35%, S 8.92% Literature References: Partially reversible gastric proton pump inhibitor. Prepn: S. Souda et al., EP 268956; eidem, US 5045552 (1988, 1991 both to Eisai). Pharmacology: H. Goto et al., Arzneim.-Forsch. 41, 635 (1991). Mode of action: M. Morii, N. Takeguchi, J. Biol. Chem. 268, 21553 (1993). HPLC determn in plasma: H. Nakai et al., J. Chromatogr. B 660, 211 (1994). Clinical pharmacokinetics: S. Yasuda et al., Int. J. Clin. Pharmacol. Ther. 32, 466 (1994). Review of clinical trials in acid peptic diseases: M. L. Cloud et al., Dig. Dis. Sci. 43, 993-1000 (1998); of pharmacology and clinical experience in gastro-esophageal reflux disease: B. Thjodleifsson, Expert Opin. Pharmacother. 5, 137-149 (2004). Properties: White crystals from CH2Cl2/ether, mp 99-100¡ã (dec). Melting point: mp 99-100¡ã (dec) Derivative Type: Sodium salt CAS Registry Number: 117976-90-6 Manufacturers' Codes: E-3810 Trademarks: Aciphex (Eisai); Pariet (Eisai) Molecular Formula: C18H20N3NaO3S Molecular Weight: 381.42 Percent Composition: C 56.68%, H 5.29%, N 11.02%, Na 6.03%, O 12.58%, S 8.41% Properties: White crystals from ether, mp 140-141¡ã (dec). Very sol in water, methanol; freely sol in ethanol, chloroform, ethyl acetate. Insol in ether, n-hexane. Melting point: mp 140-141¡ã (dec) Therap-Cat: Antiulcerative. Keywords: Antiulcerative; Gastric Proton Pump Inhibitor. |
3Â¥2012-11-11 23:26:51
hkp
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 3377.5
- ºì»¨: 4
- Ìû×Ó: 417
- ÔÚÏß: 320.6Сʱ
- ³æºÅ: 476391
- ×¢²á: 2007-12-10
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
2Â¥2012-11-11 21:36:45
cpujacs
ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 72 (³õÖÐÉú)
- ¹ó±ö: 6.872
- ½ð±Ò: 38793.2
- É¢½ð: 8615
- ºì»¨: 99
- ɳ·¢: 3
- Ìû×Ó: 7486
- ÔÚÏß: 2629.4Сʱ
- ³æºÅ: 292516
- ×¢²á: 2006-11-04
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: SciFinder/Reaxys
4Â¥2012-11-12 08:30:37
ChemInfo-VIP
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 21.8
- É¢½ð: 110
- ºì»¨: 2
- Ìû×Ó: 46
- ÔÚÏß: 21.7Сʱ
- ³æºÅ: 1947601
- ×¢²á: 2012-08-20
- רҵ: ÓлúºÏ³É
5Â¥2012-11-12 10:10:54













»Ø¸´´ËÂ¥